Docket Room
S 4238·NJ·senate

Establishes "End-Stage Kidney Disease Prevention and Innovation Act"; appropriates $10 million.

In CommitteeFiled May 14, 2026
Sponsor: Wimberly, Benjie E.
Latest Action

Introduced First Reading Senate Referred to SHH

May 14, 2026

Summary

The bill orders New Jersey’s Department of Health to establish Centers on Rare Kidney Disease Research and to provide grants to nonprofit partners for research, training, and public outreach. Up to $10 million from the General Fund would fund these activities, with priority given to minority and underserved communities. The aim is to improve early detection, develop new treatments, and ultimately reduce the need for dialysis and transplants.

AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.

Share

Track this bill

Get real-time alerts when S 4238 changes status, plus AI-powered summaries and stage predictions.

Sign up free
Docket Room · Nonpartisan legislative tracking
Docket Room IntelligencePro

Ask about your legislation

I can analyze your tracked bills, upcoming hearings, and recent changes.

AI-generated · Nonpartisan · Not legal advice